Browse > Article

Enhancement of Antigen Presentation Capability of Dendritic Cells and Activation of Macrophages by the Components of Bifidobacterium pseudocatenulatum SPM 1204  

HAN Shinha (Department of Biology, Seoul Women's University)
CHO Kyunghae (Department of Biology, Seoul Women's University)
LEE Chong-Kil (College of Pharmacy, Chungbuk National University)
SONG Youngcheon (Department of Pharmacy, Sahmyook University)
PARK So Hee (Department of Pharmacy, Sahmyook University)
HA Nam-Joo (Department of Pharmacy, Sahmyook University)
KIM Kyungjae (Department of Pharmacy, Sahmyook University)
Publication Information
Biomolecules & Therapeutics / v.13, no.3, 2005 , pp. 174-180 More about this Journal
Abstract
Antigen presenting cells (APCs), dendritic cells (DCs) and macrophages, playa critical role not only in the initiation of immune responses, but also in the induction of immune tolerance. In an effort to regulate immune responses through the modulation of APC function, we searched for and characterized APC function modulators from natural products. Bifidobacterium pseudocatenulatum SPM1204 (SPM1204) isolated from feces of healthy Korean in the age of 20s was used in this experiment. DCs and macrophages were cultured in the presence of supernatants of SPM 1204 and then examined for their activities for the presentation exogenous antigen in association with major histocompatibility complexes (MHC) and macrophage activation. SPM1204 increased class I MHC-restricted presentation of exogenous antigen (cross-presentation) in a DC cell line, DC2.4 cells. The RAW 264.7 cell line was used to test the nonspecific effect of immune reinforcement of SPM1204 as a source of biological regulating modulator for the macrophage activation, include nitric oxide (NO) production and cytokine production. Results showed that the production of NO, tumor necrosis factor (TNF)-$\alpha$, interleukin 1 (IL-1)-$\beta$ and morphological changes in macrophages were largely affected by SPM1204 in a dose-dependent manner. Our results demonstrated that SPM1204 promote cross-presentation of dendritic cells as well as the induction of NO, TNF-$\alpha$ production, and activation of macrophage.
Keywords
Bifidobacterium spp.; exogenous OVA; MHC class I; antigen presentation; macrophage activation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim, K. M., Kwon, Y. G., Chung, H. T., Yun, Y. G., Pae, H. O., Han, J. A., Ha, K. S., Kim, T. W., Kim, Y. M. (2003). Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing $NF-\kappaB$ activation. Toxicology and applied pharmacology. 190, 1-8   DOI   ScienceOn
2 Abbas, A. K., Lichrman, A. H., Pobe, J. S. (1994). Cytokines: Cellular and Molecular Immunology, second ed., pp. 240 W. B. Saunders Co., Philadelphia, PA
3 Cavaillon, J. M. (1994). Cytokines and macrophages. Biomed. Pharmacother. 48, 445-453   DOI   ScienceOn
4 Duffy, L. C., Zielezny, M. I., Riepenhoff-Talty, M., Dxyja, D. (1994). Sayahtaheri-Altaie S, Griffiths E, Ruffin D, Barrett H, Rossman J, Organ PL. Effectiveness of Bifidobaterium bifidum in mediating the clinical course of murine rotavirus diarrhea. Pediatr. Res. 35, 690-695   DOI   ScienceOn
5 Gopal, A., Shah, N. P., Roginski, H. (1996). Bile tolerance, taurochloate deconjugation and cholesterol removal by Lactobacillus acidophilius and bifidobacterium. Milchwissenschaft. 51, 619-623
6 Han, M. J., Park, H. Y., Kim, D. H. (1999). Protective effects of Bifidobacterium spp. On experimental colon carcinogenesis with 1,2-dimethylhydrazine. J. Microbiol. Biotechnol. 9, 368-370
7 Hatcher, G. E., Lambrecht, R. S. (1993). Augmentation of macro phage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J. Dairy Sci. 76, 2485-2492   DOI   ScienceOn
8 Homma, N., (1998). Bifidobacteria as a resistance factor in human beings. Bifidobact. Microfl. 7, 35-43
9 Hosono, A., Lee, J., Ametani, A., Natsume, M., Hirayama, M., Adachi, T., Kaminogawa, S. (1997). Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobaterium adolescentis M 101-4. Biosci. Biotech. Biochem. 61, 312-316   DOI   ScienceOn
10 Kado-Oka, Y., Fujiwara, S., Hirota, T. (1991). Effects of bifidobacteria cells on monogenesis response of splenocytes and several functions of phagocytes. Milchwissenshaft. 46, 626-630
11 Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., Rock, K. L. (1993). Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. UAS 90, 4942-4946
12 Kumann, J. A., Raric, J. L. (1998). The health potential of products containing bifidobacteria. In: Robinson, RK. (Ed.), Therapeutic Properties of Fermented Milks. pp.117 Elsevier Appl. Sci. London, England
13 Lee, J., Ametani, A., Enomoto, A., Sato, Y., Motoshima, H., Ike, F., Kaminogawa, S. (1993). Screening for the immunopotentiating activity of food microorganisms and enhancement of the immune response by Bifidobaterium adolescentis M101-4. Biosci. Bitotech. Biochem. 57, 2127-2132   DOI
14 Link-Amster, H., Rochat, F., Saudan, K. Y., Mignot, O., Aeshlimann, J. M. (1994). Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10, 55-64   DOI   ScienceOn
15 Rafter, J. J. (1999). The role of lactic acid bacteria in colon cancer prevention. Scand. J Gastroenterol. 30, 497-502   DOI   ScienceOn
16 Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Sayder, S. H., Russell, S. W. (1993). Expression of the nitric oxide synthase gene in the mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268, 1908-1913
17 Mitsuoka, T. (1982). Recent trends in research on intestinal flora. Bifidobact. Microfl. 1, 3-24   DOI
18 Mitsuoka T. (1994) Taxonomy and ecology of bifidobacteria. Bifidobact. Microfl. 3, 11-28
19 Roy, D., Ward, P. (1990). Evaluation ofrapid methods for differentiation of bifidobacterium species. J. Appl. Bacteriol. 69, 739-749   DOI
20 Sasaki, T., Fukami, S., Namioka, S. (1994). Enhanced resistance of mice to Escherichia coli infection induced by administration of peptidoglycan derived from Bifidobaterium thermo philum. J. Vet. Med. Sci. 53, 433-437
21 Sekine, K., Watanabe-Sekine, E., Toida, T., Kasashima, T., Kataoka, T., Hashimoto, Y. (1994).Adjuvant activity of the cell wall of Bifidobacterium infantis for in vivo immune responses in mice. Immunopharmacol. Immunotoxicol. 16, 589-609   DOI   ScienceOn
22 Shen, Z., Reznikoff, G., Dranoff, G., Rock, K. L.(1997). Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723-2730
23 Takahashi, T., Oka, T., Iwana, H., Kuwata, T., Yamamoto, Y. (1993). Immune response of mice to orally administered lactic acid bacteria Biosci. Biotech. Biochem. 57, 1557-1560   DOI
24 Yamazaki, S., Tsuyuki, S., Akashiba, H., Kamimura, H., Kimuura, M., Kawashima, T., Ueda, K. (1991). Immune response of Bifidobaterium-monoassociated mice. Bifidobact. Microfl. 10, 19-31   DOI
25 Hughes, D. B., Hoover, D. G. (1991). Bifidobacteria; their potential for use in American dairy products. Food. Technol. 45, 74-83
26 Yasui, H., Ohwaki, M. (1991). Enhancement of immune response in Peyer's patch cells cultured with Bifidobaterium breve. J. Dairy Sci. 74, 1187-1195   DOI   ScienceOn
27 Yasui, H., Nagaoka, N., Mike, A., Hayakawa, K., Ohwaki, M.. (1992). Detection of Bifidobaterium strains that induce large quantities of IgA. Microbial. Ecol. Health Dis. 5, 155-162   DOI
28 Yeh, K. Y., McAdam, A. J., Pulaski, B. A., Shastri, N., Frelinger, J. G., Lord, E. M. (1998). IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumorspecific cytolytic T lymphocytes. J. Immunol. 160, 5773-5780
29 Bea, E. A., Kim, D. H., Han, M. J., Park, H. Y., Choi, E. C. (1998). Inhibitory effects of Bifidobacterium spp. isolated from a healthy Korean on harmful enzymes of human intestinal microflora. Arch. Pharm. Res. 21, 54-61   DOI
30 Stuehr, D. J., Nathan, C. F. (1989). Nitric oxide, a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169, 1543-1555   DOI   ScienceOn